The PNC Financial Services Group, Inc. filed a Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of 1,941,390 shares of Biostem Technologies, Inc. common stock as of October 31, 2026.

Key Highlights

  • Aggregate beneficial ownership: The PNC Financial Services Group, Inc. reported beneficial ownership of 1,941,390 shares of Biostem Technologies common stock.
  • Percent of class: The reported holdings represent 10.40% of Biostem Technologies' outstanding common stock.
  • Sole voting power: PNC reported sole voting power over all 1,941,390 shares, with no shared voting power.
  • Sole dispositive power: Sole dispositive power was reported over 793,847 shares, with no shared dispositive power.
  • Fiduciary holdings: 1,691,390 shares are held at PNC Bank, National Association, and 250,000 shares at PNC Ohio Trust Company, both in a fiduciary capacity for clients.
  • Triggering event date: The event requiring this filing occurred on October 31, 2026.

PNC's Schedule 13G Filing on Biostem Technologies Common Stock

According to the filing, The PNC Financial Services Group, Inc., a Pennsylvania-organized holding company headquartered at 300 Fifth Avenue, Pittsburgh, PA 15222-2401, submitted a Schedule 13G disclosing a 10.40% beneficial ownership position in Biostem Technologies, Inc., whose principal executive offices are located at 2836 Center Port Circle, Pompano Beach, Florida 33604. The filing was signed by Gregory H. Kozich, Senior Vice President and Controller, on November 5, 2026.

The filing discloses that of the 1,941,390 shares beneficially owned in aggregate, 1,691,390 shares are held in accounts at PNC Bank, National Association in a fiduciary capacity for clients, and 250,000 shares are held in accounts at PNC Ohio Trust Company in a fiduciary capacity for clients. PNC Bank, National Association and PNC Ohio Trust Company are both identified as subsidiaries with a classification of "BK" (bank). The filing identifies PNC as a parent holding company or control person under Schedule 13G Item 3(g).

The filing certified, as required, that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer." No shared voting or dispositive power was reported. Items 5, 8, and 9 were marked not applicable, indicating no group membership and no dissolution of a group to disclose.

What Was Disclosed

The PNC Financial Services Group, Inc. reported a 10.40% beneficial ownership stake in Biostem Technologies, Inc. common stock (CUSIP 090684200), comprising 1,941,390 shares held primarily in fiduciary accounts at two PNC subsidiaries, as of October 31, 2026.